Adverse Drug Reaction
Delayed adverse events following intravenous immunoglobulin infusions are common
Published in Drug Week, September 29th, 2006
In a recently published study, investigators in Australia conducted a study "to document the incidence of immediate and delayed adverse events (AE) following intravenous immunoglobulin (IVIG) infusion in children. Immediate and delayed adverse events were prospectively recorded for 345 infusions in 58 children receiving IVIG for immunodeficiency (n=33) or immunomodulation (n=25). For each infusion adverse events were documented during the infusion and by follow up interview 4 -7 days later."
"Immediate adverse events occurred in 10.3%...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2006-09-29)
More Articles from Drug Week
- HIV/AIDS Pharmacogenetics
Pharmacogenetic characteristics determined among antiretroviral drugs in HIV/AIDS - Imaging
Risk of contrast-induced nephropathy is highest for iohexol - Market Analysis
All eyes are on Plan B's over-the-counter switch - Rheumatoid Arthritis
Kemia completes successful phase I trials for oral anti-inflammatory drug - Adrenal Cancer
Adrenal malignancy management can include laparoscopic adrenalectomy as an option - Advocacy
March of Dimes: Drug to prevent preterm birth needs prompt U.S. Food & Drug Administration approval - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
